Cargando…
T-cell regulation in Erythema Nodosum Leprosum
Leprosy is a disease caused by Mycobacterium leprae where the clinical spectrum correlates with the patient immune response. Erythema Nodosum Leprosum (ENL) is an immune-mediated inflammatory complication, which causes significant morbidity in affected leprosy patients. The underlying cause of ENL i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648259/ https://www.ncbi.nlm.nih.gov/pubmed/28991896 http://dx.doi.org/10.1371/journal.pntd.0006001 |
_version_ | 1783272367142731776 |
---|---|
author | Negera, Edessa Walker, Stephen L. Bobosha, Kidist Howe, Rawleigh Aseffa, Abraham Dockrell, Hazel M. Lockwood, Diana N. |
author_facet | Negera, Edessa Walker, Stephen L. Bobosha, Kidist Howe, Rawleigh Aseffa, Abraham Dockrell, Hazel M. Lockwood, Diana N. |
author_sort | Negera, Edessa |
collection | PubMed |
description | Leprosy is a disease caused by Mycobacterium leprae where the clinical spectrum correlates with the patient immune response. Erythema Nodosum Leprosum (ENL) is an immune-mediated inflammatory complication, which causes significant morbidity in affected leprosy patients. The underlying cause of ENL is not conclusively known. However, immune-complexes and cell-mediated immunity have been suggested in the pathogenesis of ENL. The aim of this study was to investigate the regulatory T-cells in patients with ENL. Forty-six untreated patients with ENL and 31 non-reactional lepromatous leprosy (LL) patient controls visiting ALERT Hospital, Ethiopia were enrolled to the study. Blood samples were obtained before, during and after prednisolone treatment of ENL cases. Peripheral blood mononuclear cells (PBMCs) were isolated and used for immunophenotyping of regulatory T-cells by flow cytometry. Five markers: CD3, CD4 or CD8, CD25, CD27 and FoxP3 were used to define CD4(+) and CD8(+) regulatory T-cells. Clinical and histopathological data were obtained as supplementary information. All patients had been followed for 28 weeks. Patients with ENL reactions had a lower percentage of CD4(+) regulatory T-cells (1.7%) than LL patient controls (3.8%) at diagnosis of ENL before treatment. After treatment, the percentage of CD4(+)regulatory T-cells was not significantly different between the two groups. The percentage of CD8(+) regulatory T-cells was not significantly different in ENL and LL controls before and after treatment. Furthermore, patients with ENL had higher percentage of CD4(+) T-ells and CD4(+)/CD8(+) T-cells ratio than LL patient controls before treatment. The expression of CD25 on CD4(+) and CD8(+) T-cells was not significantly different in ENL and LL controls suggesting that CD25 expression is not associated with ENL reactions while FoxP3 expression on CD4(+) T-cells was significantly lower in patients with ENL than in LL controls. We also found that prednisolone treatment of patients with ENL reactions suppresses CD4(+) T-cell but not CD8(+) T-cell frequencies. Hence, ENL is associated with lower levels of T regulatory cells and higher CD4(+)/CD8(+) T-cell ratio. We suggest that this loss of regulation is one of the causes of ENL. |
format | Online Article Text |
id | pubmed-5648259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-56482592017-11-03 T-cell regulation in Erythema Nodosum Leprosum Negera, Edessa Walker, Stephen L. Bobosha, Kidist Howe, Rawleigh Aseffa, Abraham Dockrell, Hazel M. Lockwood, Diana N. PLoS Negl Trop Dis Research Article Leprosy is a disease caused by Mycobacterium leprae where the clinical spectrum correlates with the patient immune response. Erythema Nodosum Leprosum (ENL) is an immune-mediated inflammatory complication, which causes significant morbidity in affected leprosy patients. The underlying cause of ENL is not conclusively known. However, immune-complexes and cell-mediated immunity have been suggested in the pathogenesis of ENL. The aim of this study was to investigate the regulatory T-cells in patients with ENL. Forty-six untreated patients with ENL and 31 non-reactional lepromatous leprosy (LL) patient controls visiting ALERT Hospital, Ethiopia were enrolled to the study. Blood samples were obtained before, during and after prednisolone treatment of ENL cases. Peripheral blood mononuclear cells (PBMCs) were isolated and used for immunophenotyping of regulatory T-cells by flow cytometry. Five markers: CD3, CD4 or CD8, CD25, CD27 and FoxP3 were used to define CD4(+) and CD8(+) regulatory T-cells. Clinical and histopathological data were obtained as supplementary information. All patients had been followed for 28 weeks. Patients with ENL reactions had a lower percentage of CD4(+) regulatory T-cells (1.7%) than LL patient controls (3.8%) at diagnosis of ENL before treatment. After treatment, the percentage of CD4(+)regulatory T-cells was not significantly different between the two groups. The percentage of CD8(+) regulatory T-cells was not significantly different in ENL and LL controls before and after treatment. Furthermore, patients with ENL had higher percentage of CD4(+) T-ells and CD4(+)/CD8(+) T-cells ratio than LL patient controls before treatment. The expression of CD25 on CD4(+) and CD8(+) T-cells was not significantly different in ENL and LL controls suggesting that CD25 expression is not associated with ENL reactions while FoxP3 expression on CD4(+) T-cells was significantly lower in patients with ENL than in LL controls. We also found that prednisolone treatment of patients with ENL reactions suppresses CD4(+) T-cell but not CD8(+) T-cell frequencies. Hence, ENL is associated with lower levels of T regulatory cells and higher CD4(+)/CD8(+) T-cell ratio. We suggest that this loss of regulation is one of the causes of ENL. Public Library of Science 2017-10-09 /pmc/articles/PMC5648259/ /pubmed/28991896 http://dx.doi.org/10.1371/journal.pntd.0006001 Text en © 2017 Negera et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Negera, Edessa Walker, Stephen L. Bobosha, Kidist Howe, Rawleigh Aseffa, Abraham Dockrell, Hazel M. Lockwood, Diana N. T-cell regulation in Erythema Nodosum Leprosum |
title | T-cell regulation in Erythema Nodosum Leprosum |
title_full | T-cell regulation in Erythema Nodosum Leprosum |
title_fullStr | T-cell regulation in Erythema Nodosum Leprosum |
title_full_unstemmed | T-cell regulation in Erythema Nodosum Leprosum |
title_short | T-cell regulation in Erythema Nodosum Leprosum |
title_sort | t-cell regulation in erythema nodosum leprosum |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648259/ https://www.ncbi.nlm.nih.gov/pubmed/28991896 http://dx.doi.org/10.1371/journal.pntd.0006001 |
work_keys_str_mv | AT negeraedessa tcellregulationinerythemanodosumleprosum AT walkerstephenl tcellregulationinerythemanodosumleprosum AT boboshakidist tcellregulationinerythemanodosumleprosum AT howerawleigh tcellregulationinerythemanodosumleprosum AT aseffaabraham tcellregulationinerythemanodosumleprosum AT dockrellhazelm tcellregulationinerythemanodosumleprosum AT lockwooddianan tcellregulationinerythemanodosumleprosum |